Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ademetionine in Obstructive Hypertrophic Cardiomyopathy
NCT07367724Phase 2Recruiting
- Sponsor
- National Center for Cardiovascular Disease
- Start
- Jan 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of S-adenosylmethionine in hypertrophic cardiomyopathy (HCM), sponsored by National Center for Cardiovascular Disease. Started Jan 2026; status: recruiting.
02
Drugs
S-adenosylmethionine
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on NCT07367724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07367724.